Suicide risk and prevention during the COVID-19 pandemic
2020 · The Lancet Psychiatry · 1,546 citations
https://doi.org/10.1016/s2215-0366(20)30171-1
M
Mark Sinyor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
218
Papers
7.8K
Citations
36
h-index
85
i10-index
Mark Sinyor is an academic researcher from Sunnybrook Health Science Centre. The author has contributed to research in topics: Suicide and Self-Harm Studies & Mental Health Treatment and Access & COVID-19 and Mental Health. The author has an h-index of 36, co-authored 186 publications.
ORCID: 0000-0002-7756-2584Papers by this author
worksSuicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries
2021 · The Lancet Psychiatry · 732 citations
https://doi.org/10.1016/s2215-0366(21)00091-2
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
2024 · The Canadian Journal of Psychiatry · 247 citations
https://doi.org/10.1177/07067437241245384
Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials?
2010 · The Journal of Clinical Psychiatry · 187 citations
https://doi.org/10.4088/jcp.08r04516blu
The Lancet Commission on self-harm
2024 · The Lancet · 81 citations
https://doi.org/10.1016/s0140-6736(24)01121-8
The effect of economic downturn, financial hardship, unemployment, and relevant government responses on suicide
2024 · The Lancet Public Health · 40 citations
https://doi.org/10.1016/s2468-2667(24)00152-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat